These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11336174)

  • 1. Elevated plasma (1-->3)-beta-D-glucan, a fungal cell wall constituent, in a subgroup of Crohn disease.
    Chiba M; Mikami K; Iizuka M; Yukawa M; Watanabe S; Takazoe M; Fukushima T; Koganei K; Kishibe T
    Scand J Gastroenterol; 2001 Apr; 36(4):447-8. PubMed ID: 11336174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombocytosis in ulcerative colitis and regional enteritis].
    Mohr P; Straub PW
    Schweiz Med Wochenschr; 1970 Jul; 100(27):1142-7. PubMed ID: 5524944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasculitis in the course of Lesniowski-Crohn disease and ulcerative colitis].
    Szaefer D
    Pol Tyg Lek; 1993 Jun 21-28; 48(25-26):563-4. PubMed ID: 8008651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of platelet count as an activity index in chronic inflammatory intestinal diseases].
    Olm Font M; Guevara C; García-Pugés A; Navarro S
    Med Clin (Barc); 1988 Oct; 91(10):397. PubMed ID: 3216739
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous toxemia in nonspecific colitis].
    Golovenko OV; Eroshkina TD; Kirkin BV; Musin II
    Sov Med; 1990; (1):67-9. PubMed ID: 2349521
    [No Abstract]   [Full Text] [Related]  

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations].
    Pintér M; Pintérová KM; Drahosová M; Rejchrt S; Douda T; Tachecí I; Kopácová M; Bures J
    Cas Lek Cesk; 2007; 146(11):863-7. PubMed ID: 18069213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
    Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 47 can be a new target molecule for intestinal fibrosis related to inflammatory bowel disease.
    Honzawa Y; Nakase H; Takeda Y; Nagata K; Chiba T
    Inflamm Bowel Dis; 2010 Dec; 16(12):2004-6. PubMed ID: 20186932
    [No Abstract]   [Full Text] [Related]  

  • 13. [Crohn's disease and ulcerative colitis].
    Lémann M; Allez M
    Rev Prat; 2004 Dec; 54(19):2161-6. PubMed ID: 15724595
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis.
    Obayashi T; Yoshida M; Tamura H; Aketagawa J; Tanaka S; Kawai T
    J Med Vet Mycol; 1992; 30(4):275-80. PubMed ID: 1432487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
    Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
    J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case from practice (371). Ulcerative colitis].
    Vogt T; Lehmann FS
    Praxis (Bern 1994); 1997 Jan; 86(1-2):23-5. PubMed ID: 9045276
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can OCT be used to distinguish accurately between patients with ulcerative colitis and those with Crohn's disease?
    Herfarth H
    Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):172-3. PubMed ID: 16265178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein C deficiency in ulcerative colitis].
    Tromm A; Hüppe D; May B
    Dtsch Med Wochenschr; 1992 Jul; 117(28-29):1130-1. PubMed ID: 1623840
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers for inflammatory bowel disease.
    Foley KF; Kao P
    Clin Lab Sci; 2007; 20(2):84-8. PubMed ID: 17557707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.